Literature DB >> 14571130

How common are common fragile sites in humans: interindividual variation in the distribution of aphidicolin-induced fragile sites.

S R Denison1, R K Simper, I F Greenbaum.   

Abstract

To obtain an estimate of the variation in common fragile sites (CFSs) among individuals, aphidicolin (APC)-induced chromosomal breakage data were analyzed for 20 karyotypically normal adult humans. As it is specifically designed to meet the analytical requirements for considering fragile sites as presence/absence characters in single individuals, the FSM methodology (Böhm et al., 1995) was used to statistically distinguish fragile from nonfragile sites. These analyses indicated that the APC-induced fragile sites are not ubiquitous but vary extensively among individuals; the per-individual number of fragile sites ranged from as few as seven to as many as 20. Of the 45 different sites identified as fragile, 19 (42%) occurred in more than half of the individuals, but only two sites (3p14 and 16q23) were fragile in all of the individuals; 12 (27% of the total) were fragile in single individuals only. Although these analyses provide statistical confirmation (and initial estimates of population variation) for 43 of the 88 APC-inducible fragile sites currently recognized as occurring among humans, they are consistent with the hypothesis that many of the currently recognized human CFSs have been erroneously identified. These results indicate the need for per-individual statistical identification of CFSs for larger samples of individuals and that studies of particular fragile sites should be conducted on individuals documented to be fragile at the loci under consideration. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571130     DOI: 10.1159/000073411

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  10 in total

1.  Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1(LINE) repeats.

Authors:  Lena M Brueckner; Evgeny Sagulenko; Elisa M Hess; Diana Zheglo; Anne Blumrich; Manfred Schwab; Larissa Savelyeva
Journal:  Hum Genet       Date:  2012-04-05       Impact factor: 4.132

2.  DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.

Authors:  Christine E Lehman; Laura W Dillon; Yuri E Nikiforov; Yuh-Hwa Wang
Journal:  Carcinogenesis       Date:  2017-03-01       Impact factor: 4.944

3.  Replication dynamics at common fragile site FRA6E.

Authors:  Elisa Palumbo; Laura Matricardi; Elena Tosoni; Aaron Bensimon; Antonella Russo
Journal:  Chromosoma       Date:  2010-06-29       Impact factor: 4.316

4.  FRA18C: a new aphidicolin-inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage.

Authors:  Kim Debacker; Birgitta Winnepenninckx; Neta Ben-Porat; David FitzPatrick; Rob Van Luijk; Stefaan Scheers; Batsheva Kerem; R Frank Kooy
Journal:  J Med Genet       Date:  2007-05       Impact factor: 6.318

Review 5.  How unfinished business from S-phase affects mitosis and beyond.

Authors:  Hocine W Mankouri; Diana Huttner; Ian D Hickson
Journal:  EMBO J       Date:  2013-09-24       Impact factor: 11.598

6.  Genomic instability in the PARK2 locus is associated with Parkinson's disease.

Authors:  Wojciech Ambroziak; Dariusz Koziorowski; Kinga Duszyc; Paulina Górka-Skoczylas; Anna Potulska-Chromik; Jarosław Sławek; Dorota Hoffman-Zacharska
Journal:  J Appl Genet       Date:  2015-04-02       Impact factor: 3.240

Review 7.  Are common fragile sites merely structural domains or highly organized "functional" units susceptible to oncogenic stress?

Authors:  Alexandros G Georgakilas; Petros Tsantoulis; Athanassios Kotsinas; Ioannis Michalopoulos; Paul Townsend; Vassilis G Gorgoulis
Journal:  Cell Mol Life Sci       Date:  2014-09-20       Impact factor: 9.261

Review 8.  Common fragile sites: genomic hotspots of DNA damage and carcinogenesis.

Authors:  Ke Ma; Li Qiu; Kristin Mrasek; Jun Zhang; Thomas Liehr; Luciana Gonçalves Quintana; Zheng Li
Journal:  Int J Mol Sci       Date:  2012-09-20       Impact factor: 6.208

9.  Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.

Authors:  S-W Park; J Ludes-Meyers; D B Zimonjic; M E Durkin; N C Popescu; C M Aldaz
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

Review 10.  Genome instability at common fragile sites: searching for the cause of their instability.

Authors:  Annapaola Franchitto
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.